新型表观遗传分子疗法用于印记疾病
Sung Eun Wang1, Yong-Hui Jiang2,3,4
1Department of Genetics, Yale University School of Medicine, 333 Cedar street, New Haven, CT, 06520, USA.
Molecular psychiatry
|August 25, 2023
概括
由基因调节中断引起的基因印记障碍很快可能会通过准它们的分子基础来治疗. 新的表观遗传疗法,包括基因编辑,在临床前和临床研究中显示出前景.
科学领域:
- 遗传学 是一个遗传学.
- 表观遗传学 在表观遗传学中,表观遗传学是指表观遗传学.
- 分子生物学分子生物学
背景情况:
- 基因组印记障碍是由于表观遗传失调引起的异常基因表达引起的.
- 目前针对这些疾病的治疗方法基本上是症状性的,并没有解决潜在的分子机制.
- 印制基因为基于表观遗传学的新型治疗策略提供了独特的目标.
研究的目的:
- 对基因组印记障碍的新兴分子治疗候选者进行审查和突出展示.
- 讨论在临床前和临床环境中小分子,反感性寡核酸和基于CRISPR的基因组编辑的进展.
- 确定将这些新型疗法转化为临床实践的挑战.
主要方法:
- 对印记障碍治疗候选药物的临床前和临床研究的文献综述.
- 专注于分子方法,包括小分子,反意义寡核酸和CRISPR基因编辑.
- 分析这些疗法从实验室研究到临床应用的转化.
主要成果:
- 在发现和测试小分子,反意义寡核酸和CRISPR介导的基因组编辑方面取得了重大进展.
- 这些分子方法代表了对印记疾病的有希望的新疗法策略.
- 早期的研究表明,可能会发生等位基因的重新激活或减少.
结论:
- 针对分子机制的表观遗传疗法为治疗基因组印记障碍提供了一个新的前沿.
- 小分子,ASO和基因组编辑显示出治疗潜力,正在进行临床前和临床研究.
- 将这些先进的疗法,特别是基因组编辑,转化为广泛的临床使用,存在重大障碍.
更多相关视频
10:44In Vitro Selection of Engineered Transcriptional Repressors for Targeted Epigenetic Silencing
Published on: May 5, 2023
1.5K
13:47Lentiviral Vector Platform for the Efficient Delivery of Epigenome-editing Tools into Human Induced Pluripotent Stem Cell-derived Disease Models
Published on: March 29, 2019
9.7K
相关概念视频
02:30Genomic Imprinting and Inheritance
34.7K
Diploid organisms inherit genetic material through chromosomes from both parents. Copies of the same gene are known as alleles. In most cases, both alleles are simultaneously expressed and allow various cellular processes to function optimally. If one of the alleles is missing or mutated, the expression of the other allele can compensate; however, this is not true for all genes.
The expression of some genes depends on which parent passed the gene to the offspring, through a phenomenon known as...
The expression of some genes depends on which parent passed the gene to the offspring, through a phenomenon known as...
34.7K
01:46Epigenetic Regulation
31.1K
Epigenetic mechanisms play an essential role in healthy development. Conversely, precisely regulated epigenetic mechanisms are disrupted in diseases like cancer.
31.1K
01:24Methods of Nuclear Reprogramming
1.8K
Nuclear reprogramming is a process of transforming one cell type into an unrelated cell type by epigenetic changes that alter the cell’s original gene expression pattern. Such epigenetic changes force cells to express a different set of genes, which play a significant role in inducing transformation into other cell types. Nuclear reprogramming offers applications in reproductive cloning for livestock propagation and regenerative medicine — developing patient-specific cells for...
1.8K
01:22Imprinting
9.8K
Behavioral imprinting is observed in some newborn animals and occurs when they develop strong and specific attachments to another animal (usually a parent) following brief, early-life exposures. Offspring imprint onto parents within a brief period after birth or hatching; this time window is called the critical period. Once imprinting occurs, the bond established between the parents and their offspring is usually long-lasting.
9.8K
01:32Chromatin Modification in iPS Cells
1.7K
Chromatin modification alters gene expression; therefore, scientists can add histone-modifying enzymes, histone variants, and chromatin remodeling complexes to somatic cells to aid reprogramming into pluripotent stem (iPS) cells.
Compact chromatin makes reprogramming difficult. Enzymes, such as histone demethylases and acetyltransferases, are often added during reprogramming to loosen the chromatin, making the DNA more accessible to transcription factors. Molecules that inhibit histone...
Compact chromatin makes reprogramming difficult. Enzymes, such as histone demethylases and acetyltransferases, are often added during reprogramming to loosen the chromatin, making the DNA more accessible to transcription factors. Molecules that inhibit histone...
1.7K
01:29Somatic to iPS Cell Reprogramming
2.2K
Reprogramming alters the gene expression in somatic cells, transforming them into induced pluripotent stem (iPS) cells over several generations. Scientists can reprogram cells by introducing genes for four transcription factors—Oct4, Sox2, Klf4, and c-Myc (OSKM) by viral or non-viral methods. These factors are also known as Yamanaka factors after Shinya Yamanaka, who first generated iPS cells using mouse skin cells. Yamanaka was awarded the Nobel Prize in Physiology or Medicine in 2012...
2.2K